
Results
5
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
5 companies
Pharma Mar
Market Cap: €1.8b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€99.50
7D
3.6%
1Y
34.6%
Oryzon Genomics
Market Cap: €216.0m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.73
7D
-2.1%
1Y
-0.7%
ACS Actividades de Construcción y Servicios
Market Cap: €35.8b
ACS, Actividades de Construcción y Servicios, S.A.
ACS
€137.20
7D
11.9%
1Y
143.7%
Ercros
Market Cap: €310.0m
Manufactures and sells chemical and pharmaceutical products in Spain and internationally.
ECR
€3.38
7D
-1.0%
1Y
12.5%
Adolfo Domínguez
Market Cap: €49.8m
Engages in the design, manufacture, acquisition, sale, marketing, retail, import, and export of ready-made garments, footwear, handbags and accessories, household linen, furniture, and decorative objects.
ADZ
€5.40
7D
-1.8%
1Y
14.9%